MMP12 and neoplasm: Our proteomic finding and the non-tumour origin of MMP12 also highlights the necessity that further studies should implement a holistic approach (meaning that profiling must consider all cells present in the tumour microenvironment) to avoid the risk of a selection bias for biomarkers that are tumour shed.